KINSTANZ (U.S. Trademark Serial Number 86461300) is a United States trademark of Glaxo Group Limited. The goods and services include: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines . The correspondent is CHRISTOPHER M. HANES of GLAXOSMITHKLINE.
This trademark was filed on November 21, 2014 as United States Trademark Application Serial Number 86461300. The trademark application was registered on December 15, 2015 as U.S. Trademark Registration 4869495.
Trademark PTO Status History
July 01, 2022 – CANCELLED SEC. 8 (6-YR)
December 15, 2020 – COURTESY REMINDER – SEC. 8 (6-YR) E-MAILED
December 15, 2015 – REGISTERED-PRINCIPAL REGISTER
September 29, 2015 – OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
September 29, 2015 – PUBLISHED FOR OPPOSITION
September 09, 2015 – NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
August 27, 2015 – LAW OFFICE PUBLICATION REVIEW COMPLETED
August 25, 2015 – APPROVED FOR PUB – PRINCIPAL REGISTER
View full trademark status information at USPTO
Ownership History
Glaxo Group Limited
Glaxo Group Limited
Glaxo Group Limited
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.